Massachusetts General Hospital, Site #047

Boston, Massachusetts 02114

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myeloid Leukemia, GIST

Studies at this site

• A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor — Completed
• Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) — Stopped early